<![CDATA[ANANDA Scientific Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=37870>Wed, 29 Apr 2026 09:59:48 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD]]>https://www.newswire.co.kr/newsRead.php?no=1023126Sun, 16 Nov 2025 13:25:00 +0900<![CDATA[아난다 사이언티픽-벤타, PTSD 치료제 발전 위한 양해각서 체결]]>https://www.newswire.co.kr/newsRead.php?no=1023127Sun, 16 Nov 2025 13:25:00 +0900<![CDATA[ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation]]>https://www.newswire.co.kr/newsRead.php?no=999188Wed, 23 Oct 2024 14:45:00 +0900<![CDATA[아난다 사이언티픽과 UCLA 데이비드 게펜 의과대학, 금연을 위한 Nantheia™ ATL5 평가 임상시험 개시 발표]]>https://www.newswire.co.kr/newsRead.php?no=999190Wed, 23 Oct 2024 14:45:00 +0900<![CDATA[ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain]]>https://www.newswire.co.kr/newsRead.php?no=998796Thu, 17 Oct 2024 14:30:00 +0900<![CDATA[아난다 사이언티픽, 오피오이드 사용 장애와 만성 통증의 동시 발생 치료에서 Nantheia™ ATL5를 평가하는 임상시험 발표]]>https://www.newswire.co.kr/newsRead.php?no=998798Thu, 17 Oct 2024 14:30:00 +0900<![CDATA[ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)]]>https://www.newswire.co.kr/newsRead.php?no=964117Wed, 29 Mar 2023 13:40:00 +0900<![CDATA[아난다 사이언티픽, 사회불안장애의 잠재적 새 치료법 평가 위한 FDA 승인 임상에 첫 환자 등록 발표]]>https://www.newswire.co.kr/newsRead.php?no=964118Wed, 29 Mar 2023 13:40:00 +0900<![CDATA[University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)]]>https://www.newswire.co.kr/newsRead.php?no=963270Wed, 15 Mar 2023 13:30:00 +0900<![CDATA[네브래스카대학교 의료원 및 ANANDA Scientific, FDA 승인을 받은 외상후 스트레스장애에 대한 임상시험에 첫 환자가 등록했음을 발표]]>https://www.newswire.co.kr/newsRead.php?no=963271Wed, 15 Mar 2023 13:30:00 +0900<![CDATA[ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)]]>https://www.newswire.co.kr/newsRead.php?no=956876Thu, 01 Dec 2022 09:50:00 +0900<![CDATA[아난다 사이언티픽, FDA로부터 사회불안장애(SAD) 치료 연구 임상시험 위한 IND 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=956877Thu, 01 Dec 2022 09:50:00 +0900<![CDATA[University of Nebraska Medical Center and ANANDA Scientific announce FDA approval of the IND for a Clinical Trial exploring Treatment for Post-Traumatic Stress Disorder (PTSD)]]>https://www.newswire.co.kr/newsRead.php?no=944738Wed, 18 May 2022 16:30:00 +0900<![CDATA[아난다-네브래스카 메디컬 센터, PTSD 치료 신약 FDA 임상 승인 발표]]>https://www.newswire.co.kr/newsRead.php?no=944739Wed, 18 May 2022 16:30:00 +0900<![CDATA[ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain]]>https://www.newswire.co.kr/newsRead.php?no=940602Wed, 09 Mar 2022 08:45:00 +0900<![CDATA[아난다 사이언티픽과 뉴욕대 그로스먼 의학대학원, 신경병증 환자 약물 사용 제한 임상 시험에 첫 환자 등록]]>https://www.newswire.co.kr/newsRead.php?no=940603Wed, 09 Mar 2022 08:45:00 +0900<![CDATA[ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)]]>https://www.newswire.co.kr/newsRead.php?no=937499Tue, 04 Jan 2022 21:05:00 +0900<![CDATA[아난다 사이언티픽, 오피오이드 사용 장애 치료제 FDA 임상 IND 승인]]>https://www.newswire.co.kr/newsRead.php?no=937500Tue, 04 Jan 2022 21:05:00 +0900<![CDATA[ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to Be Clinically Evaluated for Opioid Use Disorder]]>https://www.newswire.co.kr/newsRead.php?no=932364Tue, 19 Oct 2021 20:05:00 +0900<![CDATA[아난다 사이언티픽의 리퀴드 스트럭처™ 칸나비디올(CBD), 오피오이드 사용 장애 대상 임상 평가]]>https://www.newswire.co.kr/newsRead.php?no=932365Tue, 19 Oct 2021 20:05:00 +0900<![CDATA[ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)]]>https://www.newswire.co.kr/newsRead.php?no=931344Thu, 30 Sep 2021 13:40:00 +0900<![CDATA[아난다 사이언티픽, UCLA 데이비드 게펜 의과대학과 오피오이드 오남용 치료 위해 리퀴드 스트럭처 CBD 이용하는 임상 진행]]>https://www.newswire.co.kr/newsRead.php?no=931345Thu, 30 Sep 2021 13:40:00 +0900<![CDATA[ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)]]>https://www.newswire.co.kr/newsRead.php?no=925002Wed, 09 Jun 2021 14:40:00 +0900<![CDATA[아난다 사이언티픽과 뉴욕대학교 그로스만 의과대학, 외상 후 스트레스 장애(PTSD) 치료를 위한 리퀴드 스트럭처기술 이용 칸나비디올(CBD)을 평가하는 임상시험에 첫 번째 환자 등록했다고 발표]]>https://www.newswire.co.kr/newsRead.php?no=925003Wed, 09 Jun 2021 14:40:00 +0900